$HYPR

Hyperfine

Share on X

$HYPR

Hyperfine

Past 12mo:4mentions1voices

Share on X

All voices4 mentions since Apr 2026calls only

Loading price chart…

Frequently asked

Who mentions $HYPR most on Surfaced?

@bmsinvests (BMSInvests) mentions $HYPR most — 4 mentions in the past 12 months.

When was $HYPR first mentioned on Surfaced?

The earliest tracked mention of $HYPR in the Surfaced archive was on Apr 29, 2026.

How many voices track $HYPR?

1 FinTwit voice has mentioned $HYPR 4 times in the past 12 months.

What kind of voices mention $HYPR most?

$HYPR is mentioned most by Long Research voices on Surfaced.

Recent mentions

4 mentions

@bmsinvestsMay 26, 2026 · 12:21 PM

$HYPR Hyperfine to join the Russell 2000 and 3000 indexes Hyperfine, Inc. (Nasdaq: $HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared AI-powered portable MRI system for the brain—the Swoop® system—today announced that Hyperfine is expected to join the broad-market Russell 3000® Index and the small-cap Russell 2000® Index at the conclusion of the June 2026 Russell Reconstitution, according to a preliminary list of additions posted by FTSE Russell on May 22, 2026. Hyperfine’s inclusion will become effective after the U.S. market close on June 26, 2026.

Open on X

@bmsinvestsMay 26, 2026 · 8:05 AM

Still extremely interested in $HYPR First FDA-cleared AI-powered portable MRI system with a massively expanding global TAM (200+ IP’s). Hospitals, surgeries, battlefield etc. Growing adoption and approvals worldwide (UK, India etc.). Transitioning from R&D to commercialisation (10 units sold in Q126). Partners with and grant recipients of the Bill & Melinda Gates Foundation. Collaboration with $NVDA to enhance their Optive AI solution. Insiders own ~31% of the float including the founder with 17m shares (16.6%). Hardly any sales, only to cover tax. 20% tute ownership. Vanguard own 4.34%. $GOOG have owned 900k shares since 2022 and haven’t sold. Gross margins expanding from 41.3% to 50.7%. Cash burn and operating loss decreasing 13% and 21% YoY respectively. R&D expenses decreased 24% YoY. Asset/liability ratio is OK. $40.8m cash and equivalents with runway into 2028, easing dilution. Good R/R for a small position for me. NFA.

Open on X

@bmsinvestsMay 1, 2026 · 4:01 PM

$HYPR running up again👀

Open on X

@bmsinvestsApr 29, 2026 · 4:06 PM

What’s everyone buying today then?👀 Personally, I’ve bought: $ONDS $SRFM $UAMY Eyeing up new positions in: $LPTH $KRKNF $SPAI $PRZO $HYPR doing well today also on my watchlist as they introduced India’s first portable MRI.

Open on X